NATIONAL INSTITUTES OF HEALTH
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
Phase 1
Completed
- Conditions
- Healthy, no Evidence of Disease
- Interventions
- Other: placeboOther: pharmacological studyOther: laboratory biomarker analysis
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 36
- Registration Number
- NCT00489372
- Locations
- πΊπΈ
Northwestern University, Chicago, Illinois, United States
πΊπΈRoswell Park Cancer Institute, Buffalo, New York, United States
Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Phase 2
Completed
- Conditions
- Hormone-Resistant Prostate CancerRecurrent Prostate Carcinoma
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Pharmacological Study
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 23
- Registration Number
- NCT00486642
- Locations
- π¨π¦
BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada
π¨π¦Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
π¨π¦Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada
Effect of Diet on Vascular Disease in Pre-Menopausal Women
Completed
- Conditions
- Cardiovascular DiseasesInflammationTriglyceridesInsulinVascular Disease
- First Posted Date
- 2007-06-11
- Last Posted Date
- 2019-12-17
- Target Recruit Count
- 47
- Registration Number
- NCT00484861
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2
Terminated
- Conditions
- Stage IB Pancreatic CancerStage III Pancreatic CancerStage IA Pancreatic CancerIntraductal Papillary Mucinous Neoplasm of the PancreasRecurrent Pancreatic CancerStage IIA Pancreatic CancerStage IIB Pancreatic Cancer
- Interventions
- Procedure: conventional surgeryOther: immunohistochemistry staining methodGenetic: protein expression analysisProcedure: biopsyOther: pharmacological studyOther: laboratory biomarker analysis
- First Posted Date
- 2007-06-05
- Last Posted Date
- 2014-10-16
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 6
- Registration Number
- NCT00482625
- Locations
- πΊπΈ
University of California Medical Center At Irvine-Orange Campus, Orange, California, United States
Cancer Markers Associated With Occupational Exposure to Trichloroethylene
Completed
- Conditions
- EpidemiologyNeoplasmsIndustrial Hygiene
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 125
- Registration Number
- NCT00481611
- Locations
- π¨π³
Guangdong National Poison Control Center (NPCC), Guangzhou, China
Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China
Completed
- Conditions
- Lung Neoplasms
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 3720
- Registration Number
- NCT00482118
- Locations
- π¨π³
The University of Hong Kong, Hong Kong, China
π¨π³Kunming Medical University, Kunming, China
π¨π³China Medical University, Shenyang, China
Benign Reproductive Tissue Analysis for Endometrial Cancer Markers
Completed
- Conditions
- Oophorectomy for Benign ReasonsHysterectomy
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 359
- Registration Number
- NCT00481754
- Locations
- πΊπΈ
Magee Women's hospital, Pittsburgh, Pennsylvania, United States
Relationship of Genetic Differences to the Development of Chromosome Abnormalities
Terminated
- Conditions
- Radiation Exposure
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 361
- Registration Number
- NCT00481793
- Locations
- π·πΊ
Southern Urals Biophysics Institute, Ozyorsk, Russian Federation
Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2007-06-01
- Last Posted Date
- 2014-10-30
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 94
- Registration Number
- NCT00481078
- Locations
- πΊπΈ
City of Hope, Duarte, California, United States
Radiation Exposure and Thyroid Disease in Kazakhstan
Completed
- Conditions
- Thyroid CancerThyroid NodulesOther Thyroid Disease
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2019-12-16
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 117
- Registration Number
- NCT00480428
- Locations
- π°πΏ
Semipalatinsk State Medical Academy, Semipalatinsk, Kazakhstan